Valuation: Mega Genomics Limited

Market Cap 1.32B 1.55B 198M 177M 164M 148M 277M 18.85B 281M 1.95B 779M 9.87B 743M 727M 31.24B P/E 2024
47.5x
P/E 2025 49.1x
Enterprise Value 910M 1.07B 137M 122M 113M 102M 191M 13.01B 194M 1.35B 537M 6.81B 513M 502M 21.56B EV / Sales 2024
11.5x
EV / Sales 2025 4.44x
Free-Float
42.54%
Yield 2024 *
-
Yield 2025 2.23%
1 day-0.57%
1 week-2.32%
Current month-0.86%
1 month-1.83%
3 months-2.04%
6 months-0.93%
Current year-3.40%
1 week 6.8
Extreme 6.8
7.25
1 month 6.8
Extreme 6.795
7.3
Current year 5
Extreme 5
7.53
1 year 5
Extreme 5
7.53
3 years 5
Extreme 5
12.4
5 years 5
Extreme 5
21
10 years 5
Extreme 5
21
Manager TitleAgeSince
Chief Executive Officer 46 17/01/2024
Chief Tech/Sci/R&D Officer 46 -
Chief Operating Officer 43 -
Director TitleAgeSince
Director/Board Member 46 -
Director/Board Member 45 06/08/2021
Director/Board Member 48 06/08/2021
Date Insider Type Main position Quantity % Market Cap. Importance
9/10/26 A Other

Founder

-1,000,000 0.4458%
1/21/25 A Other

Director

273,970 0.1181%
1/21/25 A Other

Founder

800,000 0.3448%
Change 5-day change 1-year change 3-year change Capi.($)
-0.57%-2.32%-3.40%-11.40% 199M
-0.38%-4.97%+11.39%+32.01% 115B
+2.65%+1.59%+1.36%+112.57% 100B
+1.21%+6.95%+122.65%+1,043.24% 61.18B
+1.44%+1.62%-6.81%+89.51% 29.09B
+0.75%+9.62%+45.75%+82.51% 29.25B
+2.36%+3.20%+43.64%+94.00% 27.02B
-1.13%-3.00%+25.51%+392.96% 21.62B
-0.72%+2.93%-17.96%-1.64% 20.81B
+0.26%-1.13%-5.19%+31.49% 16.97B
Average +0.56%+1.64%+21.69%+186.52% 42.15B
Weighted average by Cap. +0.92%+0.79%+26.95%+226.22%

Financials

2024 2025
Net sales 164M 193M 24.64M 22.07M 20.36M 18.43M 34.46M 2.35B 35.01M 243M 96.92M 1.23B 92.48M 90.51M 3.89B 247M 291M 37.09M 33.22M 30.64M 27.73M 51.86M 3.53B 52.69M 366M 146M 1.85B 139M 136M 5.85B
Net income 45.04M 53.03M 6.76M 6.05M 5.59M 5.05M 9.45M 644M 9.6M 66.63M 26.58M 337M 25.37M 24.83M 1.07B 27.02M 31.81M 4.05M 3.63M 3.35M 3.03M 5.67M 386M 5.76M 39.97M 15.95M 202M 15.22M 14.89M 640M
Net Debt -459M -540M -68.84M -61.66M -56.88M -51.47M -96.25M -6.56B -97.81M -679M -271M -3.43B -258M -253M -10.87B -409M -482M -61.37M -54.97M -50.71M -45.89M -85.81M -5.84B -87.2M -605M -241M -3.06B -230M -225M -9.69B
Projected Income Statement - Annual - Mega Genomics Limited
Logo Mega Genomics Limited
Mega Genomics Ltd is an investment holding company primarily engaged in the provision of genetic testing and cancer screening services. The Company operates through Namely Consumer Genetic Testing Services segment and Cancer Screening Services segment. The Company's testing services include Brain Health Assessment Package, Alimentation Capability Assessment Package, Parkinson's Disease Risk Assessment, Full-scale Cancer Risk Assessment Package, Cardiovascular and Cerebrovascular Disease Risk Assessment Package and others. The Company is also engaged in the provision of vitro diagnostics (IVD) pipeline products, including consumer genetic testing products and disease screening products. The Company primarily conducts its businesses in domestic market.
Employees
196
Date Price Change Volume
29/10/26 HK$6.955 -0.57% 7,200
28/10/26 HK$6.995 -1.34% 4,800
27/10/26 HK$7.090 -0.70% 5,600
26/10/26 HK$7.140 +0.28% 83,400
23/10/26 HK$7.120 -0.77% 118,400
  1. Stock Market
  2. Stocks
  3. 6667 Stock